Page last updated: 2024-08-24

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Cancer of Prostate

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Cancer of Prostate in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Ho, CT; Hseu, YC; Kao, JY; Kuo, PT; Lin, VC; Lin, YC; Way, TD; Yang, HL1
Hu, H; Jiang, C; Kim, SH; Lee, EO; Lee, HJ; Lü, J; Wang, L; Xiang, Q; Zhang, J; Zhao, Y1
Hu, H; Kim, SH; Lee, HJ; Lü, J; Zhang, J1
Huang, CH; Kao, JY; Kuo, PT; Lin, JK; Lin, TP; Liu, LC; Way, TD1
Chai, Y; Hu, H; Kim, SH; Lee, HJ; Lü, J; Wang, L; Zhang, J1
Jeong, SJ; Kim, HC; Kim, HS; Kim, SH; Lee, HJ; Lim, S; Lü, J; Park, KY1
Higgins, LA; Kim, KH; Kim, SH; Li, L; Liao, JD; Lu, J; Nkhata, K; Shaik, AA; Wang, L; Xing, C; Zhang, J; Zhang, Y1
Gho, YS; Ji, ST; Lee, HM; Lee, SJ; Lee, SR; Mar, W1

Other Studies

8 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Cancer of Prostate

ArticleYear
Penta-O-galloyl-β-D-glucose suppresses EGF-induced eIF3i expression through inhibition of the PI3K/AKT/mTOR pathway in prostate cancer cells.
    Journal of agricultural and food chemistry, 2014, Sep-10, Volume: 62, Issue:36

    Topics: Bone Neoplasms; Cell Line, Tumor; Epidermal Growth Factor; Eukaryotic Initiation Factor-3; Gene Expression; Humans; Hydrolyzable Tannins; Male; Neoplasm Metastasis; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; TOR Serine-Threonine Kinases; Transfection

2014
Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:9

    Topics: Androgens; Animals; Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-X Protein; Caspases; Cell Line, Tumor; Cell Proliferation; Cell-Free System; G1 Phase; Humans; Hydrogen Peroxide; Hydrolyzable Tannins; Interleukin-6; Intracellular Space; Male; Mice; Mice, Nude; Prostatic Neoplasms; S Phase; STAT3 Transcription Factor; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2008
Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1.
    Carcinogenesis, 2009, Volume: 30, Issue:5

    Topics: Amino Acid Chloromethyl Ketones; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Nucleus; Cyclin D1; DNA Replication; Humans; Hydrolyzable Tannins; Male; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms

2009
Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
    Journal of agricultural and food chemistry, 2009, Apr-22, Volume: 57, Issue:8

    Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Down-Regulation; Epidermal Growth Factor; ErbB Receptors; Humans; Hydrolyzable Tannins; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Prostatic Neoplasms; RNA, Messenger; Transcription, Genetic

2009
Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.
    Molecular cancer therapeutics, 2009, Volume: 8, Issue:10

    Topics: Adenine; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Enzyme Activation; Gene Knockdown Techniques; GTPase-Activating Proteins; Humans; Hydrolyzable Tannins; Male; Membrane Proteins; Mice; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Protein Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sirolimus; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay

2009
1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells.
    Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:11

    Topics: 1-Phosphatidylinositol 4-Kinase; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Capillaries; Cell Line, Tumor; Endothelial Cells; Endothelium, Vascular; Humans; Hydrolyzable Tannins; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Phosphorylation; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Umbilical Veins; Vascular Endothelial Growth Factor A

2010
Mouse prostate proteome changes induced by oral pentagalloylglucose treatment suggest targets for cancer chemoprevention.
    Current cancer drug targets, 2011, Volume: 11, Issue:7

    Topics: Administration, Oral; Animals; Biomarkers; Blotting, Western; Body Weight; Hydrolyzable Tannins; Male; Maximum Tolerated Dose; Mice; Mice, Inbred C57BL; Organ Size; Prostate; Prostatic Neoplasms; Proteome; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2011
1,2,3,4,6-Penta-O-galloyl-beta-D-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor.
    Cancer letters, 2004, May-10, Volume: 208, Issue:1

    Topics: Cell Division; Cell Movement; Collagen; Drug Combinations; Endothelium, Vascular; Fibrosarcoma; Humans; Hydrolyzable Tannins; Laminin; Male; Paeonia; Plant Extracts; Prostatic Neoplasms; Protein Binding; Proteoglycans; Receptors, Vascular Endothelial Growth Factor; Sodium-Potassium-Exchanging ATPase; Tannins; Umbilical Veins; Vascular Endothelial Growth Factor A

2004